Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
IntroductionCertain HLA variants are associated with an increased risk of hypersensitivity reactions to specific drugs. Both the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Dutch Pharmacogenetics Working Group (DPWG) have issued actionable HLA gene - drug interaction guideline...
Saved in:
Main Authors: | Lisanne E. N. Manson (Author), Jesse J. Swen (Author), Henk-Jan Guchelaar (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis
by: Lisanne E. N. Manson, et al.
Published: (2021) -
Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions
by: Lisanne E. N. Manson, et al.
Published: (2022) -
Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines
by: Heshu Abdullah-Koolmees, et al.
Published: (2021) -
Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice
by: Alireza Tafazoli, et al.
Published: (2021) -
Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole
by: Sylvia D. Klomp, et al.
Published: (2024)